
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
1 International Agency for Research on Cancer (IARC), Lyon, France and2 Cancer Prevention Fellowship Program, Division of Cancer Prevention, National Cancer Institute, NIH, Bethesda, Maryland
Requests for reprints: Aimee Kreimer, National Cancer Institute, 6130 Executive Boulevard, Suite 2131, Bethesda, MD 20892-7333. Phone: 301-594-0839; Fax: 301-480-9939. E-mail: kreimera{at}mail.nih.gov
Mucosal human papillomaviruses (HPV) are the cause of cervical cancer and likely a subset of head and neck squamous cell carcinomas (HNSCC), yet the global prevalence and type distribution of HPV in HNSCC remains unclear. We systematically reviewed published studies of HNSCC biopsies that employed PCR-based methods to detect and genotype HPV to describe the prevalence and type distribution of HPV by anatomic cancer site. Geographic location and study size were investigated as possible sources of variability. In the 5,046 HNSCC cancer specimens from 60 studies, the overall HPV prevalence was 25.9% [95% confidence interval (95% CI), 24.7-27.2]. HPV prevalence was significantly higher in oropharyngeal SCCs (35.6% of 969; 95% CI, 32.6-38.7) than oral SCCs (23.5% of 2,642; 95% CI, 21.9-25.1) or laryngeal SCCs (24.0% of 1,435; 95% CI, 21.8-26.3). HPV16 accounted for a larger majority of HPV-positive oropharyngeal SCCs (86.7%; 95% CI, 82.6-90.1) compared with HPV-positive oral SCCs (68.2%; 95% CI, 64.4-71.9) and laryngeal SCCs (69.2%; 95% CI, 64.0-74.0). Conversely, HPV18 was rare in HPV-positive oropharyngeal SCCs (2.8%; 95% CI, 1.3-5.3) compared with other head and neck sites [34.1% (95% CI, 30.4-38.0) of oral SCCs and 17.0% (95% CI, 13.0-21.6) of laryngeal SCCs]. Aside from HPV16 and HPV18, other oncogenic HPVs were rarely detected in HNSCC. Tumor sitespecific HPV prevalence was higher among studies from North America compared with Europe and Asia. The high HPV16 prevalence and the lack of HPV18 in oropharyngeal compared with other HNSCCs may point to specific virus-tissue interactions. Small sample size and publication bias complicate the assessment of the prevalence of HPV in head and neck sites beyond the oropharynx.
This article has been cited by other articles:
![]() |
K. J. Duncan, K. A. Eckert, and G. A. Clawson Mechanisms of Growth Inhibition in Human Papillomavirus Positive and Negative Cervical Cancer Cells by the Chloromethyl Ketone Protease Inhibitor, Succinyl-Alanine-Alanine-Proline-Phenylalanine Chloromethyl Ketone J. Pharmacol. Exp. Ther., July 1, 2009; 330(1): 359 - 366. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Chen, C. J. Marsit, B. C. Christensen, E.A. Houseman, M. D. McClean, J. F. Smith, J. T. Bryan, M. R. Posner, H. H. Nelson, and K. T. Kelsey Genetic variation in the vitamin C transporter, SLC23A2, modifies the risk of HPV16-associated head and neck cancer Carcinogenesis, June 1, 2009; 30(6): 977 - 981. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. JO, A. JUHASZ, K. ZHANG, C. RUEL, S. LOERA, S. P. WILCZYNSKI, Y. YEN, X. LIU, J. ELLENHORN, D. LIM, et al. Human Papillomavirus Infection as a Prognostic Factor in Oropharyngeal Squamous Cell Carcinomas Treated in a Prospective Phase II Clinical Trial Anticancer Res, May 1, 2009; 29(5): 1467 - 1474. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Lassen, J. G. Eriksen, S. Hamilton-Dutoit, T. Tramm, J. Alsner, and J. Overgaard Effect of HPV-Associated p16INK4A Expression on Response to Radiotherapy and Survival in Squamous Cell Carcinoma of the Head and Neck J. Clin. Oncol., April 20, 2009; 27(12): 1992 - 1998. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Applebaum, T. N. Ruhlen, F. R. Kronenberg, C. Hayes, and E. S. Peters Oral Cancer Knowledge, Attitudes and Practices: A Survey of Dentists and Primary Care Physicians in Massachusetts J Am Dent Assoc, April 1, 2009; 140(4): 461 - 467. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Tezal, M. Sullivan Nasca, D. L. Stoler, T. Melendy, A. Hyland, P. J. Smaldino, N. R. Rigual, and T. R. Loree Chronic Periodontitis-Human Papillomavirus Synergy in Base of Tongue Cancers Arch Otolaryngol Head Neck Surg, April 1, 2009; 135(4): 391 - 396. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. G. Sikora, L. G. Morris, and E. M. Sturgis Bidirectional Association of Anogenital and Oral Cavity/Pharyngeal Carcinomas in Men Arch Otolaryngol Head Neck Surg, April 1, 2009; 135(4): 402 - 405. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. N. Savani, S. Goodman, and A. J. Barrett Can Routine Posttransplant HPV Vaccination Prevent Commonly Occurring Epithelial Cancers after Allogeneic Stem Cell Transplantation? Clin. Cancer Res., April 1, 2009; 15(7): 2219 - 2221. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. Klussmann, J. J. Mooren, M. Lehnen, S. M.H. Claessen, M. Stenner, C. U. Huebbers, S. J. Weissenborn, I. Wedemeyer, S. F. Preuss, J. M.J.A.A. Straetmans, et al. Genetic Signatures of HPV-related and Unrelated Oropharyngeal Carcinoma and Their Prognostic Implications Clin. Cancer Res., March 1, 2009; 15(5): 1779 - 1786. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Lohavanichbutr, J. Houck, W. Fan, B. Yueh, E. Mendez, N. Futran, D. R. Doody, M. P. Upton, D. G. Farwell, S. M. Schwartz, et al. Genomewide Gene Expression Profiles of HPV-Positive and HPV-Negative Oropharyngeal Cancer: Potential Implications for Treatment Choices Arch Otolaryngol Head Neck Surg, February 1, 2009; 135(2): 180 - 188. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Cazap A Global Vision from Scientific Knowledge to Reality ASCO Educational Book, January 1, 2009; 2009(1): 56 - 60. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Meyer, K. M. Applebaum, C. S. Furniss, E. S. Peters, B. G. Luckett, J. F. Smith, J. Bryan, M. D. McClean, C. Marsit, and K. T. Kelsey Human Papillomavirus-16 Modifies the Association between Fruit Consumption and Head and Neck Squamous Cell Carcinoma Cancer Epidemiol. Biomarkers Prev., December 1, 2008; 17(12): 3419 - 3426. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. W. Lee, M. E. Anderson, S. Wu, and J. H. Lee Development of an Adenoviral Vaccine Against E6 and E7 Oncoproteins to Prevent Growth of Human Papillomavirus-Positive Cancer Arch Otolaryngol Head Neck Surg, December 1, 2008; 134(12): 1316 - 1323. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Chen, E. M. Sturgis, A. K. El-Naggar, Q. Wei, and G. Li Combined effects of the p53 codon 72 and p73 G4C14-to-A4T14 polymorphisms on the risk of HPV16-associated oral cancer in never-smokers Carcinogenesis, November 1, 2008; 29(11): 2120 - 2125. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Termine, V. Panzarella, S. Falaschini, A. Russo, D. Matranga, L. Lo Muzio, and G. Campisi HPV in oral squamous cell carcinoma vs head and neck squamous cell carcinoma biopsies: a meta-analysis (1988-2007) Ann. Onc., October 1, 2008; 19(10): 1681 - 1690. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Singh and D. G. Pfister Individualized Treatment Selection in Patients With Head and Neck Cancer: Do Molecular Markers Meet the Challenge? J. Clin. Oncol., July 1, 2008; 26(19): 3114 - 3116. [Full Text] [PDF] |
||||
![]() |
N. E. Goldstein, E. Genden, and R. S. Morrison Palliative Care for Patients With Head and Neck Cancer: "I Would Like a Quick Return to a Normal Lifestyle" JAMA, April 16, 2008; 299(15): 1818 - 1825. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. R. Giuliano and D. Salmon The Case for a Gender-Neutral (Universal) Human Papillomavirus Vaccination Policy in the United States: Point Cancer Epidemiol. Biomarkers Prev., April 1, 2008; 17(4): 805 - 808. [Full Text] [PDF] |
||||
![]() |
S. Marur and A. A. Forastiere Head and Neck Cancer: Changing Epidemiology, Diagnosis, and Treatment Mayo Clin. Proc., April 1, 2008; 83(4): 489 - 501. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Gillison, G. D'Souza, W. Westra, E. Sugar, W. Xiao, S. Begum, and R. Viscidi Distinct Risk Factor Profiles for Human Papillomavirus Type 16-Positive and Human Papillomavirus Type 16-Negative Head and Neck Cancers J Natl Cancer Inst, March 19, 2008; 100(6): 407 - 420. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. C. Spanos, A. Hoover, G. F. Harris, S. Wu, G. L. Strand, M. E. Anderson, A. J. Klingelhutz, W. Hendriks, A. D. Bossler, and J. H. Lee The PDZ Binding Motif of Human Papillomavirus Type 16 E6 Induces PTPN13 Loss, Which Allows Anchorage-Independent Growth and Synergizes with Ras for Invasive Growth J. Virol., March 1, 2008; 82(5): 2493 - 2500. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Fakhry, W. H. Westra, S. Li, A. Cmelak, J. A. Ridge, H. Pinto, A. Forastiere, and M. L. Gillison Improved Survival of Patients With Human Papillomavirus-Positive Head and Neck Squamous Cell Carcinoma in a Prospective Clinical Trial J Natl Cancer Inst, February 20, 2008; 100(4): 261 - 269. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M. Smith, D. Wang, L. M. Rubenstein, W. A. Morris, L. P. Turek, and T. H. Haugen Association between p53 and Human Papillomavirus in Head and Neck Cancer Survival Cancer Epidemiol. Biomarkers Prev., February 1, 2008; 17(2): 421 - 427. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Choong and E. Vokes Expanding Role of the Medical Oncologist in the Management of Head and Neck Cancer CA Cancer J Clin, January 1, 2008; 58(1): 32 - 53. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. C. Ukpo, E. J. Moore, D. I. Smith, H. Williams, C. D. Higgins, D. H. Crawford, B. J. Braakhuis, P. J. Snijders, C. R. Leemans, and M. L. Gillison Human Papillomavirus and Oropharyngeal Cancer N. Engl. J. Med., September 13, 2007; 357(11): 1156 - 1158. [Full Text] [PDF] |
||||
![]() |
G. D'Souza, A. R. Kreimer, R. Viscidi, M. Pawlita, C. Fakhry, W. M. Koch, W. H. Westra, and M. L. Gillison Case-Control Study of Human Papillomavirus and Oropharyngeal Cancer N. Engl. J. Med., May 10, 2007; 356(19): 1944 - 1956. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Syrjanen Human Papillomaviruses in Head and Neck Carcinomas N. Engl. J. Med., May 10, 2007; 356(19): 1993 - 1995. [Full Text] [PDF] |
||||
![]() |
A. C. Hoover, W. C. Spanos, G. F. Harris, M. E. Anderson, A. J. Klingelhutz, and J. H. Lee The Role of Human Papillomavirus 16 E6 in Anchorage-Independent and Invasive Growth of Mouse Tonsil Epithelium Arch Otolaryngol Head Neck Surg, May 1, 2007; 133(5): 495 - 502. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.C.R. Ragin, F. Modugno, and S.M. Gollin The Epidemiology and Risk Factors of Head and Neck Cancer: a Focus on Human Papillomavirus Journal of Dental Research, February 1, 2007; 86(2): 104 - 114. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Saslow, P. E. Castle, J. T. Cox, D. D. Davey, M. H. Einstein, D. G. Ferris, S. J. Goldie, D. M. Harper, W. Kinney, A.-B. Moscicki, et al. American Cancer Society Guideline for Human Papillomavirus (HPV) Vaccine Use to Prevent Cervical Cancer and Its Precursors CA Cancer J Clin, January 1, 2007; 57(1): 7 - 28. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Fakhry and M. L. Gillison Clinical Implications of Human Papillomavirus in Head and Neck Cancers J. Clin. Oncol., June 10, 2006; 24(17): 2606 - 2611. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. E. Castle, J. Jeronimo, M. Schiffman, R. Herrero, A. C. Rodriguez, M. C. Bratti, A. Hildesheim, S. Wacholder, L. R. Long, L. Neve, et al. Age-Related Changes of the Cervix Influence Human Papillomavirus Type Distribution Cancer Res., January 15, 2006; 66(2): 1218 - 1224. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Dong, U. Kloz, R. Accardi, S. Caldeira, W.-M. Tong, Z.-Q. Wang, L. Jansen, M. Durst, B. S. Sylla, L. Gissmann, et al. Skin Hyperproliferation and Susceptibility to Chemical Carcinogenesis in Transgenic Mice Expressing E6 and E7 of Human Papillomavirus Type 38 J. Virol., December 1, 2005; 79(23): 14899 - 14908. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |